71 results
8-K
EX-99.1
PIRS
Pieris Pharmaceuticals Inc
10 May 23
Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates
7:30am
at the American Thoracic Society (ATS) 2023 International Conference in May 2023 for both PRS-220 and PRS-400
BOSTON, MA, May 10, 2023 – Pieris Pharmaceuticals
424B5
yzsi euhv
4 Nov 22
Prospectus supplement for primary offering
5:10pm
8-K
EX-99.1
r7qmnqpf6gdsl
2 Nov 22
Pieris Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:43am
8-K
EX-99.1
gzvkdl8d09ic1pqu9
13 Sep 22
PIERIS PHARMACEUTICALS SUPERIOR MEDICINES THROUGH EFFICIENT BIOLOGY CORPORATE PRESENTATION September 2022
8:23am
8-K
EX-99.2
vlgaocvlvg33vsi914e
4 Aug 22
Pieris Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:15am
8-K
EX-99.1
jt2s x5uqxhcr
8 Jun 22
PIERIS PHARMACEUTICALS SUPERIOR MEDICINES THROUGH EFFICIENT BIOLOGY CORPORATE PRESENTATION June 2022
7:48am
8-K
EX-99.1
0qbnju
3 Jan 22
Pieris Pharmaceuticals Announces Successful Completion of Safety Milestone and Initiation of Efficacy Portion of Phase 2A Trial of PRS-060/AZD1402
7:04am
8-K
EX-99.1
in9vp06yjdg8rzpg
2 Nov 21
Results of Operations and Financial Condition
7:18am